The estimated Net Worth of Charles Dadswell is at least $15.8 Milione dollars as of 21 February 2023. Mr. Dadswell owns over 5,282 units of Illumina Inc stock worth over $1,491,469 and over the last 11 years he sold ILMN stock worth over $12,572,998. In addition, he makes $1,727,720 as Senior Vice President, General Counsel e Secretary at Illumina Inc.
Charles has made over 86 trades of the Illumina Inc stock since 2014, according to the Form 4 filled with the SEC. Most recently he exercised 5,282 units of ILMN stock worth $659,352 on 21 February 2023.
The largest trade he's ever made was exercising 33,750 units of Illumina Inc stock on 3 March 2016 worth over $4,213,013. On average, Charles trades about 1,138 units every 27 days since 2014. As of 21 February 2023 he still owns at least 11,948 units of Illumina Inc stock.
You can see the complete history of Mr. Dadswell stock trades at the bottom of the page.
Charles E. Dadswell is the Senior Vice President, General Counsel, Secretary of Illumina Inc. since April 22, 2013. Mr. Dadswell joins Illumina with more than 20 years of leadership and legal experience at health care-focused technology companies. Most recently, he was Vice President, General Counsel for North and Latin America and Corporate Director of Global Intellectual Property at bioMerieux. In this role, he was responsible for a global intellectual property matters and legal matters in North and Latin America. Prior to bioMerieux, he was General Counsel of BioDelivery Sciences International, a specialty pharmaceutical company; and oversaw US intellectual property in a variety of positions with Glaxo, GlaxoWellcome and GlaxoSmithKline. Mr. Dadswell holds a LLM in patent law and trade regulation from The George Washington University Law School, a JD from the Thomas M. Cooley Law School and a bachelor's in science from Ferris State University.
As the Senior Vice President, General Counsel e Secretary of Illumina Inc, the total compensation of Charles Dadswell at Illumina Inc is $1,727,720. There are 4 executives at Illumina Inc getting paid more, with Mostafa Ronaghi having the highest compensation of $3,541,310.
Charles Dadswell is 62, he's been the Senior Vice President, General Counsel e Secretary of Illumina Inc since 2013. There are 4 older and 18 younger executives at Illumina Inc. The oldest executive at Illumina Inc is John Thompson, 71, who is the Lead Independent Director.
Charles's mailing address filed with the SEC is 5200 ILLUMINA WAY, , SAN DIEGO, CA, 92122.
Over the last 22 years, insiders at Illumina Inc have traded over $412,190,379 worth of Illumina Inc stock and bought 13,386 units worth $1,243,499 . The most active insiders traders include John Wendell Thompson, Jay T Flatley e Robert Nelsen. On average, Illumina Inc executives and independent directors trade stock every 5 days with the average trade being worth of $954,700. The most recent stock trade was executed by Jacob Thaysen on 22 February 2024, trading 7,330 units of ILMN stock currently worth $991,676.
at illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. these studies will help make the realization of personalized medicine possible. with such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. as a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. illumina’s innovative, array-based solutions for dna, rna, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.
Illumina Inc executives and other stock owners filed with the SEC include: